Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study locations section was updated to show current site entries across US states and international regions, and the revision tag was updated to v3.3.3.SummaryDifference2%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study; revision updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedNotice about potential data delays due to a lapse in government funding was removed.SummaryDifference0.2%

- Check60 days agoChange DetectedCore study data such as title, status, enrollment, and outcomes appear unchanged. The screenshots show only minor UI/layout adjustments.SummaryDifference0.3%

- Check74 days agoChange DetectedUpdated date-related labels and newer timestamps were added; older date references and an Expanded Access note were removed. Overall, the changes update timing information without altering core content.SummaryDifference0.9%

- Check88 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.